Considering the huge demand for its products, Oushadhi, the government of Kerala owned company producing about 450 ayurvedic formulations, is planning to increase the production capacity of its Aasavarishtam plant to 30 lakh litres from the existing 10 lakh in next year.
To achieve the target, the production of Aasavarishtam (37 varieties of Arishtams) will be shifted to a new facility which is under construction now. The total project cost including the new plant construction and technology upgradation is Rs.20 crore. The plant is scheduled to begin operation in February, 2014, said R R Shukhla, managing director of Oushadhi.
“The production increase is to meet the requirements of the government hospitals and dispensaries in Kerala and also the continually growing demand for Oushadhi products all over India. Oushadhi is the only supplier of medicines to the government health institutions in the state. Production capacity of Arishtams at the new plant is estimated to increase by approximately 30 lakh liters on commissioning the unit. The total investment in the plant will be Rs.20 crore, out of which Rs.5 crore were given by central ayush department and Rs.4 crore were funded by government of Kerala. Remaining Rs.11 crore is taken from company account,” Shukhla said in an interview with Pharmabiz in Thrissur.
For capacity increase, the company is upgrading the production technology with most modern machinery which is being set up. The new capacity upgradation project including the plant is called ‘Centre of Excellence for Ayurveda Pharmaceuticals’. According to Shukhla, thirty percent increase in the production of Arishtams is expected with the introduction of the new technology. Another advantage is that manual labour can be reduced with the opening of the new plant whose work was started 18 months ago and is expected to complete in another two months.
K Sasidharan, the general manager of Oushadhi, while interacting with Pharmabiz said one of the advantages of the introduction of new technology is that it will help to analyze and test the quality of the product stage wise. There are four stages of quality testing which can be carried out periodically. The aging process of the products can also be reduced. He said Kottakkal Arya Vaidyasala is using the same technology for production of more quantity.
Ayurvedic formulations including Arishtam, Thailam, Liquid Kashaayam, Lehyam and Ghrutham are manufactured at Oushadhi at present. According to Shukhla, the company is planning to use the modern technology to upgrade the production capacity of all varieties of drugs manufacturing at present at the unit. Now, an additional product, Bhasma, will be launched for commercial production along with Arishtams.
Regarding increase in the turnover, Shukhla said a 20 per cent increase in the turnover is expected next year after introduction of the modern plant. Last fiscal, the company’s turnover was Rs.70 crore. He said the only capacity shortage the company faces now is on tablet production which will be addressed within one year.
Source:Pharmabiz
To achieve the target, the production of Aasavarishtam (37 varieties of Arishtams) will be shifted to a new facility which is under construction now. The total project cost including the new plant construction and technology upgradation is Rs.20 crore. The plant is scheduled to begin operation in February, 2014, said R R Shukhla, managing director of Oushadhi.
“The production increase is to meet the requirements of the government hospitals and dispensaries in Kerala and also the continually growing demand for Oushadhi products all over India. Oushadhi is the only supplier of medicines to the government health institutions in the state. Production capacity of Arishtams at the new plant is estimated to increase by approximately 30 lakh liters on commissioning the unit. The total investment in the plant will be Rs.20 crore, out of which Rs.5 crore were given by central ayush department and Rs.4 crore were funded by government of Kerala. Remaining Rs.11 crore is taken from company account,” Shukhla said in an interview with Pharmabiz in Thrissur.
For capacity increase, the company is upgrading the production technology with most modern machinery which is being set up. The new capacity upgradation project including the plant is called ‘Centre of Excellence for Ayurveda Pharmaceuticals’. According to Shukhla, thirty percent increase in the production of Arishtams is expected with the introduction of the new technology. Another advantage is that manual labour can be reduced with the opening of the new plant whose work was started 18 months ago and is expected to complete in another two months.
K Sasidharan, the general manager of Oushadhi, while interacting with Pharmabiz said one of the advantages of the introduction of new technology is that it will help to analyze and test the quality of the product stage wise. There are four stages of quality testing which can be carried out periodically. The aging process of the products can also be reduced. He said Kottakkal Arya Vaidyasala is using the same technology for production of more quantity.
Ayurvedic formulations including Arishtam, Thailam, Liquid Kashaayam, Lehyam and Ghrutham are manufactured at Oushadhi at present. According to Shukhla, the company is planning to use the modern technology to upgrade the production capacity of all varieties of drugs manufacturing at present at the unit. Now, an additional product, Bhasma, will be launched for commercial production along with Arishtams.
Regarding increase in the turnover, Shukhla said a 20 per cent increase in the turnover is expected next year after introduction of the modern plant. Last fiscal, the company’s turnover was Rs.70 crore. He said the only capacity shortage the company faces now is on tablet production which will be addressed within one year.
Source:Pharmabiz
No comments:
Post a Comment